Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto-Culver appointments

This article was originally published in The Rose Sheet

Executive Summary

Company appoints three new directors to its board following its November break from Sally Beauty, Alberto-Culver states Dec. 7. Kay Napier, Thomas Dattilo and George Fotiades will join the board along with President and CEO Jim Marino, firm says. The three appointees will replace A.G. Atwater, William Wirtz and Howard Bernick, who retired from the board following completion of the separation transaction, and John Miller, who joined the new board of Sally Beauty Holdings. Alberto-Culver completed its separation from Sally Beauty Nov. 16; the entities are now two separate, publicly traded companies. In December, the firm announced a reorganization plan meant to "right-size" the company (1"The Rose Sheet" Dec. 4, 2006, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel